Spinal cord astrocytoma

Summary

Spinal cord astrocytoma (MONDO:0003174) is a disease and 1 clinical trial. A subtype of spinal cord glioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	spinal cord astrocytoma
Mondo ID	MONDO:0003174
EFO	EFO:1000544
DOID	DOID:4863
NCIT	C4641
SNOMED CT	254948003
UMLS	C0349540
MedGen	91152
GARD	0023397
Anatomy (UBERON)	UBERON:0002240
Is cancer (heuristic)	no

Also known as: astrocytoma (excluding glioblastoma) of spinal cord · astrocytoma of spinal cord · astrocytoma of the spinal cord · spinal astrocytoma · spinal cord astrocytoma · spinal cord astrocytoma (excluding glioblastoma)

Disease family

This is a subtype of spinal cord glioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › nervous system cancer › central nervous system cancer › spinal cord cancer › spinal cord glioma › spinal cord astrocytoma

Related subtypes (3): spinal cord oligodendroglioma, adult spinal cord glioblastoma, ependymal tumor of spinal cord

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04211974	Not specified	UNKNOWN	Genomic Landscape of Intramedullary Astrocytoma